CSF2 and arthritic joint disease: The former model involves systemic (i.e., subcutaneous) administration of a cytokine (GM-CSF here) to mice given mBSA intra-articularly and can allow downstream pathways dependent on the particular cytokine to be delineated (refs); the widely used zymosan-induced arthritis model involves direct intra-articular injection of the arthritogen.